These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8247632)

  • 41. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials].
    Giglio MS; Farías O; Lafourcade M; Pinto ME
    Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibility of gram positive cocci to teicoplanin. Three year survey (1984-1986) at Perugia University.
    Pasticci MB; Baldelli F; Moretti A; Menichetti F; Pauluzzi S
    Boll Ist Sieroter Milan; 1989; 68(1):5-6. PubMed ID: 2535245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Short communication: Determination of methicillin resistance in staphylococci with different methods and detection of multiple antibiotic resistance].
    Cetinkol Y; Altindiş M; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2008 Jan; 42(1):119-24. PubMed ID: 18444569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility.
    Jarløv JO
    APMIS Suppl; 1999; 91():1-42. PubMed ID: 10230367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C; Denis O; Struelens MJ
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
    Cantón R; Mir N; Martínez-Ferrer M; Sánchez del Saz B; Soler I; Baquero F
    Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.
    Moore EP; Speller DC
    J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
    Bannerman TL; Wadiak DL; Kloos WE
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.
    Cremniter J; Slassi A; Quincampoix JC; Sivadon-Tardy V; Bauer T; Porcher R; Lortat-Jacob A; Piriou P; Judet T; Herrmann JL; Gaillard JL; Rottman M
    J Clin Microbiol; 2010 Apr; 48(4):1428-31. PubMed ID: 20164270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid detection of methicillin resistance in teicoplanin-resistant coagulase-negative staphylococci by a penicillin-binding protein 2' latex agglutination method.
    Knausz M; Ghidán A; Grossato A; Rozgonyi F
    J Microbiol Methods; 2005 Mar; 60(3):413-6. PubMed ID: 15649543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.
    O'Hare MD; Reynolds PE
    J Antimicrob Chemother; 1992 Dec; 30(6):753-68. PubMed ID: 1289350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.
    Ahlstrand E; Svensson K; Persson L; Tidefelt U; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1349-54. PubMed ID: 21744039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.